Compounds > diazooxonorleucine

diazooxonorleucine and Lung Neoplasms

diazooxonorleucine has been researched along with Lung Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belinsky, SA; Chen, W; Do, KC; Filipczak, P; Leng, S; Lin, Y; Saxton, B; Tessema, M1
Anand, SK; Beer, DG; Carskadon, SL; Chakravarthi, BV; Chen, G; Chinnaiyan, AM; Giordano, TJ; Goswami, MT; Palanisamy, N; Pathi, SS; Thomas, DG; Varambally, S1
Creagan, ET; Eagan, RT; Frytak, S; Ingle, JN; Nichols, WC1
Huber, KR; Roberts, J; Rosenfeld, H1
Huber, KR; Mayer, EP; Mitchell, DF; Roberts, J1

Other Studies

6 other study(ies) available for diazooxonorleucine and Lung Neoplasms

ArticleYear
Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small-cell lung cancer cells.
    Molecular carcinogenesis, 2019, Volume: 58, Issue:6

    Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Diazooxonorleucine; Down-Regulation; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Heat-Shock Proteins; Hexosamines; Humans; Lung Neoplasms

2019
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.
    Oncotarget, 2015, Sep-15, Volume: 6, Issue:27

    Topics: Adenocarcinoma; Aged; Amidophosphoribosyltransferase; Aneuploidy; Animals; Biomarkers, Tumor; Carboxy-Lyases; Cell Line, Tumor; Cell Proliferation; Chickens; Diazooxonorleucine; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Peptide Synthases; Prognosis; Purines

2015
Hypercalcemia of malignant disease.
    California medicine, 1967, Volume: 107, Issue:1

    Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Breast Neoplasms; Diazooxonorleucine; Female; Humans; Hyperkalemia; Lung Neoplasms; Male; Rats

1967
Phase II study on DON in patients with previously treated advanced lung cancer.
    Cancer treatment reports, 1982, Volume: 66, Issue:8

    Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Azo Compounds; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Diazooxonorleucine; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis

1982
Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
    International journal of cancer, 1988, May-15, Volume: 41, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Azo Compounds; Biological Transport; Colonic Neoplasms; Diazooxonorleucine; Drug Resistance; Glutamine; Humans; Isoxazoles; Kinetics; Leukemia P388; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxazoles; Tumor Cells, Cultured

1988
Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines.
    British journal of cancer, 1987, Volume: 55, Issue:6

    Topics: Antimetabolites; Azo Compounds; Cell Cycle; Cell Line; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation, Preclinical; Glutaminase; Glutamine; Humans; Isoxazoles; Lung Neoplasms; Neoplasms, Experimental; Oxazoles

1987